An interdisciplinary research team has demonstrated a durable and lasting response to a novel treatment—combined locoregional ...

A promising new study is changing the way doctors think about treating certain cancers. The research focuses on immunotherapy ...

From antibody-drug conjugates to PARP inhibitors, innovative treatments are offering new hope for patients with ...

Recent studies show that survival for men with prostate cancer that has spread to the bone is just under two years. But this ...

Scientists have created a new type of super-strong antibody that could significantly enhance cancer immunotherapy. In an ...

As Nic Enright stood in shallow center field in the middle of the seventh inning on Sunday, with his cap over his heart as he ...

Alan faced the prospect of losing his bladder when he was diagnosed with bladder cancer in 2020. Now he’s in remission thanks ...

The reductions in NIH funding and staff are happening at a time when colorectal cancer cases have been rising among younger ...

King Charles is giving a rare update on his health. The monarch, 76 — who revealed his cancer diagnosis in February 2024 — ...

After meeting the mark alongside Keytruda in PD-L1-positive breast cancer earlier this year, Gilead Sciences' antibody-drug ...

monthly treatment — had a complete remission," Dr. Don Gravenor, a medical oncologist at Baptist Cancer Center in Memphis, said. Immunotherapy uses your own immune system to fight cancer.